EVs derived from dendritic cells treated with IL‐10 decreased the severity of experimental colitis in mice (Yang et al., 2010) and improved epithelial barrier function dependent on EV miR‐146b (Nata et al., 2013). This evidence concerns the gene IL10 and colitis.